Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Unknown (R35)
Project #
5R35CA039844-12
Application #
2089990
Study Section
Special Emphasis Panel (SRC (88))
Project Start
1985-07-01
Project End
1999-04-30
Budget Start
1996-05-01
Budget End
1997-04-30
Support Year
12
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005436803
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Loehrer Sr, Patrick J; Wang, Wei; Johnson, David H et al. (2004) Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial. J Clin Oncol 22:293-9
Kurup, Anupama; Loehrer Sr, Patrick J (2004) Thymoma and thymic carcinoma: therapeutic approaches. Clin Lung Cancer 6:28-32
Kesler, Kenneth A; Wright, Cameron D; Loehrer Sr, Patrick J (2004) Thymoma: current medical and surgical management. Semin Neurol 24:63-73
Ganjoo, K N; Rieger, K M; Kesler, K A et al. (2000) Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors. Cancer 88:1051-6
Sweeney, C J; Hermans, B P; Heilman, D K et al. (2000) Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma--predominant testis cancer. J Clin Oncol 18:358-62
Miller, D K; Munshi, N; Loesch, D et al. (2000) A phase II trial of high dose epirubicin in patients with advanced breast carcinoma. Cancer 88:375-80
Sonpavde, G; Ansari, R; Walker, P et al. (2000) Phase II study of doxorubicin and paclitaxel as second-line chemotherapy of small-cell lung cancer: a Hoosier Oncology Group Trial. Am J Clin Oncol 23:68-70
Behnia, M; Foster, R; Einhorn, L H et al. (2000) Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. the Indiana University experience. Eur J Cancer 36:472-5
Loehrer Sr, P J (1999) Current approaches to the treatment of thymoma. Ann Med 31 Suppl 2:73-9
Einhorn, L H; Stender, M J; Williams, S D (1999) Phase II trial of gemcitabine in refractory germ cell tumors. J Clin Oncol 17:509-11

Showing the most recent 10 out of 109 publications